Skip to main content
. 2019 Nov 22;2(4):235–245. doi: 10.1093/pcmedi/pbz023

Figure 1 .


Figure 1

Consort diagram. Patient enrollment design of the prospective study on the effects of autologous NK cell immunotherapy against EGFR mutation-positive lung adenocarcinoma. A. Forty-eight patients were recruited and divided into 4 groups according to the EGFR mutation and NK cell treatment status. B. NK cell infusion protocol and treatment cycle design.